• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS LIAT SYSTEM; RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS LIAT SYSTEM; RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM Back to Search Results
Catalog Number 07341920190
Device Problem False Positive Result (1227)
Patient Problems No Consequences Or Impact To Patient (2199); Anxiety (2328); Unspecified Respiratory Problem (4464); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/25/2021
Event Type  malfunction  
Event Description
A customer from the us alleged on discrepant results for four patient samples when using the cobas® sars-cov-2 & influenza a/b test on the cobas® liat® system (sn (b)(4)).The 4 alleged patient samples generated a positive flu b result in initial testing.Repeat testing on another liat system or on a biofire analyzer generated a negative flu b result.Initial test on (b)(6) 2021 generated a positive result on flu b.Confirmation testing on a boiofire analyzer at another facility generated a negative result for flu b.Initial test on (b)(6) 2021 generated a positive result on flu b.Confirmation testing on a boiofire analyzer at another facility generated a negative result for flu b.Results reported on patients 1 and 2 with a notation that sample would be sent out for confirmation.Initial test on (b)(6) 2021 generated a positive result on flu b.Repeat testing generated negative results on another liat system at the same facility and on another liat system at another facility.The negative result was reported.Initial test on (b)(6) 2021 generated a positive result on flu b.Repeat testing generated negative results on another liat system at the same facility.The sample was re-tested using the biofire analyzer at another facility and a flu b result of "invalid" was obtained and reported.Investigation on the cobas liat system is on-going.Four mdrs, one per each alleged result, will be filed.
 
Manufacturer Narrative
Investigation is ongoing.A follow-up report will be filed upon the completion of the investigation.The customer issue has been alleged on the cobas liat system, product code: occ, catalog number 07341920190 and udi (b)(4).The test used on the cobas liat system is the cobas sars-cov-2 & influenza a/b test for use on the cobas liat system ((b)(4), product code: qjr).The product catalog number for the test is 09211101190.(b)(4).
 
Manufacturer Narrative
The customer's cobas® liat® system was returned for evaluation and repair.Roche received complaints alleging invalid and/or false positive results with the cobas® sars-cov-2 & influenza a/b test for use on the cobas® liat® system for one or more targets (sars-cov-2, influenza a, influenza b).When reviewing the customer-provided data associated with the reported invalid and false positive results, abnormal pcr curves were observed.Per the on-going investigation, several potential causes for the abnormal pcr growth curves leading to invalids and false positives have been identified.These include tube leaks, abnormal pcr steps, and loose thermal sensor wiring.Overall across the installed base, these issues from product use may occur sporadically.For invalid or false positive influenza results, adverse health consequences are not likely.For invalid sars-cov-2, adverse health consequences are not likely since detectability is high and testing can be performed on alternative platforms.For erroneous positive sars-cov-2 results, there is the possibility of adverse health consequences in high risk individuals.As stated in the instructions for use, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status.A cobas liat software update and a new cobas® sars-cov-2 & influenza a/b script to better identify errors and detect abnormal pcr curves will be made available in due course.Consignees have been notified.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS LIAT SYSTEM
Type of Device
RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key11377673
MDR Text Key280445231
Report Number2243471-2021-00386
Device Sequence Number1
Product Code OCC
Combination Product (y/n)N
PMA/PMN Number
K111387
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 04/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07341920190
Date Manufacturer Received03/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number2243471-03-17-2021-001-C
Patient Sequence Number1
-
-